BRD0639 is a potent PRMT5 inhibitor. BRD0639 engages the target in cells, disrupts PRMT5-RIOK1 complexes, and reduces substrate methylation. BRD0639 is a first-in-class PBM-competitive inhibitor that can support studies of PBM-dependent PRMT5 activities and the development of novel PRMT5 inhibitors that selectively target these functions.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 110 | |
2 mg | In stock | $ 209 | |
4 mg | In stock | $ 316 | |
10 mg | In stock | $ 604 | |
20 mg | In stock | $ 936 |
Description | BRD0639 is a potent PRMT5 inhibitor. BRD0639 engages the target in cells, disrupts PRMT5-RIOK1 complexes, and reduces substrate methylation. BRD0639 is a first-in-class PBM-competitive inhibitor that can support studies of PBM-dependent PRMT5 activities and the development of novel PRMT5 inhibitors that selectively target these functions. |
Chemical Formula | C21H22ClN5O4S |
Molecular Weight | 475.95 |
Solubility | DMSO: 60 mg/ml (126.06 mM) |
Storage | Powder: -20°C for 2 years In solvent: -80°C for 1 year |
bottom